Challenging Disability Discrimination in the Clinical Use of PDMP Algorithms.

State prescription drug monitoring programs (PDMPs) use proprietary, predictive software platforms that deploy algorithms to determine whether a patient is at risk for drug misuse, drug diversion, doctor shopping, or substance use disorder (SUD). Clinical overreliance on PDMP algorithm‐generated inf...

Descripción completa

Detalles Bibliográficos
Publicado en:Hastings Center Report Vol. 54; no. 1; pp. 3 - 8
Autores principales: Pendo, Elizabeth, Oliva, Jennifer
Formato: Artículo
Publicado: Wiley-Blackwell Jan2024
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=175644265&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 175644265
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00930334
        HCR
      jtl: Hastings Center Report
      issn: 00930334
      maglogo: Y
    pubinfo:
      dt: Jan2024
      vid: 54
      iid: 1
      pid: 480
      pub: Wiley-Blackwell
    artinfo:
      ui:
        175644265
        10.1002/hast.1561
      ppf: 3
      ppct: 5
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
              size: 369KB
      tig:
        atl: Challenging Disability Discrimination in the Clinical Use of PDMP Algorithms.
      aug:
        au:
          Pendo, Elizabeth
          Oliva, Jennifer
      su:
        United States
        Substance abuse risk factors
        Health services accessibility
        Substance abuse treatment
        Discrimination against people with disabilities
        Risk assessment
        Drug monitoring
        Decision making in clinical medicine
        Patient Protection & Affordable Care Act
        Algorithms
      sug:
        subj:
          Substance abuse risk factors
          Health services accessibility
          Substance abuse treatment
          Discrimination against people with disabilities
          United States
          Outpatient Mental Health and Substance Abuse Centers
          Psychiatric and Substance Abuse Hospitals
          Risk assessment
          Drug monitoring
          Decision making in clinical medicine
          Patient Protection & Affordable Care Act
          Algorithms
      keyword:
        ACA
        ADA
        algorithmic discrimination
        Americans with Disabilities Act
        clinical algorithms
        clinical ethics
        disability discrimination
        PDMPs
        section 1557 of the Affordable Care Act
        substance use disorder
        ACA
        ADA
        algorithmic discrimination
        Americans with Disabilities Act
        clinical algorithms
        clinical ethics
        disability discrimination
        PDMPs
        section 1557 of the Affordable Care Act
        substance use disorder
      ab: State prescription drug monitoring programs (PDMPs) use proprietary, predictive software platforms that deploy algorithms to determine whether a patient is at risk for drug misuse, drug diversion, doctor shopping, or substance use disorder (SUD). Clinical overreliance on PDMP algorithm‐generated information and risk scores motivates clinicians to refuse to treat—or to inappropriately treat—vulnerable people based on actual, perceived, or past SUDs, chronic pain conditions, or other disabilities. This essay provides a framework for challenging PDMP algorithmic discrimination as disability discrimination under federal antidiscrimination laws, including a new proposed rule interpreting section 1557 of the Affordable Care Act.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N